Real-world pharmacovigilance insights into drug-induced risk of alopecia
This large-scale pharmacovigilance study identified 64 drugs with significant alopecia signals, highlighting distinct demographic patterns and latency periods. The findings underscore the need for heightened clinical vigilance, gender-specific monitoring, and updates to labels to better reflect real-world risks.
Authors
- Jianxin Cui (ORCID: https://orcid.org/0000-0003-3100-1519)
- Jiaojiao Chen (ORCID: https://orcid.org/0000-0003-3137-2571)
- Huixiang Li
- Qiaoqiao Shentu
- Haijian Wei
Institutions
- Qingdao University (CN)
- Wenzhou Medical University (CN)
- Yuhuangding Hospital (CN)
- Dongyang People's Hospital (CN)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2025-11-28
- DOI
- https://doi.org/10.3389/fphar.2025.1703423
- Primary Topic
- Pharmacovigilance and Adverse Drug Reactions
- Type
- article
- Field-Weighted Citation Impact
- 0.00